Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Trials
|
October 29, 2022
High-definition transcranial direct current stimulation (HD-tDCS) as augmentation therapy in late-life depression (LLD) with suboptimal response to treatment-a study protocol for a double-blinded randomized sham-controlled trial
Sze Ting Joanna Ngan, Lap Kei Chan, Wai Chi Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 13, 2020
Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection
Kirsten E Lyke, Alexandra Singer, Andrea A Berry, et al.
Plos One
|
June 20, 2020
IMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents
Bradley Hickey, Nimfa Teneza-Mora, Joanne Lumsden, et al.
Frontiers in Immunology
|
September 15, 2023
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability
Elizabeth K Graydon, Tonia L Conner, Kim Dunham, et al.
Plos One
|
September 8, 2021
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
Marvin J Sklar, Santina Maiolatesi, Noelle Patterson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Trials
|
October 29, 2022
High-definition transcranial direct current stimulation (HD-tDCS) as augmentation therapy in late-life depression (LLD) with suboptimal response to treatment-a study protocol for a double-blinded randomized sham-controlled trial
Sze Ting Joanna Ngan, Lap Kei Chan, Wai Chi Chan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 13, 2020
Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection
Kirsten E Lyke, Alexandra Singer, Andrea A Berry, et al.
Plos One
|
June 20, 2020
IMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents
Bradley Hickey, Nimfa Teneza-Mora, Joanne Lumsden, et al.
Frontiers in Immunology
|
September 15, 2023
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability
Elizabeth K Graydon, Tonia L Conner, Kim Dunham, et al.
Plos One
|
September 8, 2021
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
Marvin J Sklar, Santina Maiolatesi, Noelle Patterson, et al.
Page
of 2